Karyopharm Therapeutics (KPTI) Q1 2022 Earnings Call Transcript [The Motley Fool]
Karyopharm Therapeutics Inc. (KPTI)
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.karyopharm.com/investor-relations
Company Research
Source: The Motley Fool
Image source: The Motley Fool.Karyopharm Therapeutics(KPTI1.20%May 05, 20228:30 a.m. ETContents::OperatorGood morning, and welcome to the Karyopharm Therapeutics first quarter 2022 earnings conference call. [Operator instructions] Please note, this event is being recorded. I would now like to turn the conference over to Elhan Webb, senior vice president, investor relations. Please go ahead.Senior Vice President, Investor RelationsThank you, operator, and thank you, all, for joining us on today's conference call to discuss the Karyopharm's first quarter 2022 financial results and recent company progress. Today, I'm joined by Richard Paulson, president and CEO; Sohanya Cheng, chief commercial officer; Dr. Reshma Rangwala, chief medical officer; Dr. Pat Judson, SVP, medical strategy; and Mike Mason, chief financial officer.This morning, we issued a press release detailing Karyopharm's financial results for the first quarter 2022. This release, along with the slide presentation that we wi
Show less
Read more
Impact Snapshot
Event Time:
KPTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KPTI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KPTI alerts
High impacting Karyopharm Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
KPTI
News
- Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care [Yahoo! Finance]Yahoo! Finance
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor) [Yahoo! Finance]Yahoo! Finance
- Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)Business Wire
- Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences [Yahoo! Finance]Yahoo! Finance
KPTI
Earnings
- 2/29/24 - Miss
KPTI
Sec Filings
- 4/23/24 - Form 4
- 4/19/24 - Form ARS
- 4/19/24 - Form DEFA14A
- KPTI's page on the SEC website